Warberg Asset Management »

Pasithea Therapeutics Corp shares owned by Warberg Asset Management

Quarter-by-quarter ownership of Pasithea Therapeutics Corp (KTTAW) shares owned by Warberg Asset Management from 13F filings

Historical chart of Warberg Asset Management investment in Pasithea Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Pasithea Therapeutics Corp held by Warberg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pasithea Therapeutics Corp by Warberg Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.2k 290k 0.02
2023-09-30 $3.8k 290k 0.01
2023-06-30 $6.2k 290k 0.02
2023-03-31 $8.7k 290k 0.03
2022-12-31 $9.5k 290k 0.03
2022-09-30 $40k 311k 0.13
2022-06-30 $20k 311k 0.06
2022-03-31 $51k 300k 0.17
2021-12-31 $81k 219k 0.37

More positions owned by Warberg Asset Management

Spdr S&p 500 Etf Tr Put Put Option
Occidental Pete Corp W Exp 08/03/202 (OXY.WS)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Invesco Qqq Tr Put Put Option
United States Stl Corp Note 5.000%11/0 (Principal)
Microchip Technology Note 1.625% 2/1 (Principal)
Interdigital Note 2.000% 6/0 (Principal)
Altair Engr Note 0.250% 6/0 (Principal)
Chart Inds Note 1.000%11/1 (Principal)
Booking Holdings Note 0.750% 5/0 (Principal)
Hubspot Note 0.375% 6/0 (Principal)
Conmed Corp Note 2.625% 2/0 (Principal)
Repligen Corp Note 0.375% 7/1 (Principal)
RH Note 9/1 (Principal)
Akamai Technologies Note 0.125% 5/0 (Principal)

View all positions for Warberg Asset Management

Top funds holding Pasithea Therapeutics Corp

Kepos Capital
Warberg Asset Management
Citadel Advisors

View all funds holding Pasithea Therapeutics Corp